KDR and neoplasm: Fucoidan-coated manganese dioxide nanoparticles (Fuco-MnO2-NPs) are able to inhibit the expression of phosphorylated vascular endothelial growth factor receptor 2 (VEGFR2) and CD31, overcoming radioresistance through dual targeting of tumor hypoxia and angiogenesis [161].